Our client was looking for support in designing, preparing, and conducting a series of launch readiness workshops for their new first-to-market rare disease product. They wanted to bring together different cross-functional and country colleagues to interact and collaborate for optimal launch strategy development.
CRA worked closely with the core client team to align on objectives and business goals for the rare disease launch. We designed themed workshops focused on key topics including the disease landscape, value proposition, evidence generation, stakeholder engagement, payer negotiation, access, and uptake. The series of workshops were attended by 60+ colleagues within the client organization and facilitated cross-market and cross-functional learnings to build a robust launch strategy.
CRA provided a springboard to the global and local teams in developing their rare disease launch strategies with a comprehensive understanding of the rare disease and product features, an integrated SWOT analysis, and a plan for key strategies and activities to implement ahead of and beyond launch.